Lataa...
Retro-inverso-D-peptides as a novel targeted immunotherapy for Type 1 Diabetes
Over the past four decades, the number of people with Type 1 Diabetes (T1D) has increased by 4% per year, making it an important public health challenge. Currently, no curative therapy exists for T1D and the only available treatment is insulin replacement. HLA-DQ8 has been shown to present antigenic...
Tallennettuna:
| Julkaisussa: | J Autoimmun |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7683378/ https://ncbi.nlm.nih.gov/pubmed/32951964 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaut.2020.102543 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|